Cytek BioSciences 

€4.06
28
+€0+0% 今天

統計

當日最高
4.08
當日最低
4.06
52週高點
5.45
52週低點
2.14
成交量
-
平均成交量
-
市值
0
本益比
-
股息殖利率
-
股息
-

即將到來

財報

7May預期
Q4 2025
下一步
-0.29
-0.2
-0.11
-0.02
預期EPS
-0.078938575
實際EPS
不適用

其他人也在關注

此清單是根據在 Stock Events 上追蹤 8EQ.STU 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Show more...
執行長
Dr. Wenbin Jiang Ph.D.
員工
702
國家
美國
ISIN
US23285D1090

上市

0 Comments

分享你的想法

FAQ

Cytek BioSciences 今天的股價是多少?
8EQ.STU 目前價格為 €4.06 EUR,過去 24 小時上漲了 +0%。在圖表上更密切關注 Cytek BioSciences 股價表現。
Cytek BioSciences 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Cytek BioSciences 的股票以代號 8EQ.STU 進行交易。
Cytek BioSciences 的股價在上漲嗎?
8EQ.STU 股票較上週上漲 +7.41%,本月上漲 +4.1%,過去一年 Cytek BioSciences 上漲 +26.09%。
Cytek BioSciences 下一次財報日期是什麼時候?
Cytek BioSciences 將於 May 07, 2026 公布下一次財報。
Cytek BioSciences 上一季度的財報如何?
8EQ.STU 上一季度的財報為每股 -0.29 EUR,預估為 -0.02 EUR,帶來 -1,600% 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Cytek BioSciences 有多少名員工?
截至 May 06, 2026,公司共有 702 名員工。
Cytek BioSciences 位於哪個產業?
Cytek BioSciences從事於Health & Wellness產業。
Cytek BioSciences 何時完成拆股?
Cytek BioSciences 最近沒有進行任何拆股。
Cytek BioSciences 的總部在哪裡?
Cytek BioSciences 的總部位於 美國 的 Fremont。